ClearPoint Neuro CLPT Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$246K-133% | $506K-19.4% | $912K+138% | ||
| $40.61M+26.0% | $36.97M+17.8% | $34.33M+12.8% | $33.59M+19.7% | $32.24M+23.2% | ||
| $15.3M+22.3% | $14.28M+16.4% | $13.28M+10.2% | $13.3M+18.0% | $12.51M+11.4% | ||
| $25.32M+28.3% | $22.69M+18.7% | $21.05M+14.6% | $20.3M+20.8% | $19.73M+32.1% | ||
| 62.3%+1.1pp | 61.4%+0.5pp | 61.3%+0.9pp | 60.4%+0.6pp | 61.2%+4.1pp | ||
| $15.04M+14.4% | $13.9M+12.1% | $13.99M+19.5% | $13.86M+28.0% | $13.15M+16.2% | ||
| $17.41M+31.5% | $16.5M+37.6% | $14.32M+25.1% | $13.87M+23.8% | $13.24M+13.9% | ||
| $19.34M+28.8% | $16.46M+13.7% | $15.5M+10.5% | $15.21M+14.2% | $15.02M+16.0% | ||
| -$26.48M-22.1% | -$24.16M-22.4% | -$22.76M-21.0% | -$22.64M-22.1% | -$21.68M-3.5% | ||
| -65.2%+2.1pp | -65.4%-2.5pp | -66.3%-4.5pp | -67.4%-1.3pp | -67.3%+12.8pp | ||
| —— | —— | —— | —— | $388.5K— | ||
| -$185K-1,750% | -$146K-265% | -$120K-233% | -$67K-81.1% | -$10K+77.3% | ||
| -$29.02M-39.7% | -$25.49M-34.8% | -$23.12M— | -$22.2M— | -$20.78M— | ||
| $45K— | $55K— | —— | —— | —— | ||
| -$29.07M-39.8% | -$25.54M-35.0% | -$23.14M-27.5% | -$22.22M-23.6% | -$20.79M-0.8% | ||
| -71.6%-7.1pp | -69.1%-8.8pp | -67.4%-7.8pp | -66.2%-2.1pp | -64.5%+14.3pp | ||
| -$1.01-32.9% | -$0.91-30.0% | -$0.84-21.7% | -$0.81-14.1% | -$0.76+9.5% | ||
| -$25.68M-23.2% | -$23.35M-24.5% | -$21.95M-22.8% | -$21.63M-22.0% | -$20.84M-3.1% | ||
| -63.2%+1.4pp | -63.2%-3.4pp | -63.9%-5.2pp | -64.4%-1.2pp | -64.7%+12.6pp | ||
| -$26.48M-22.1% | -$24.16M-22.4% | -$22.76M-21.0% | -$22.64M-22.1% | -$21.68M-3.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is ClearPoint Neuro's revenue?
- ClearPoint Neuro (CLPT) generated $40.6M in revenue over the trailing twelve months, up 26.0% year over year.
- Is ClearPoint Neuro profitable?
- ClearPoint Neuro is not currently profitable: it reported a net loss of $29.1M over the trailing twelve months, a -71.6% net margin.
- What are ClearPoint Neuro's profit margins?
- Gross margin is 62.3% and operating margin is -65.2%, with a -71.6% net margin.
- What is ClearPoint Neuro's earnings per share?
- ClearPoint Neuro's diluted EPS over the trailing twelve months is $-1.01.
- Where does ClearPoint Neuro's income statement data come from?
- Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
